🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Up to 90% of patients with Parkinson's disease (PD) have hypokinetic dysart...
Status
Unknown
Location
Central European Institute of Technology
Start Date
2023-01-10
Trial ID
NCT06416553
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
This is a single-arm, single-center feasibility trial of patients with bord...
Status
Recruiting
Location
Juravinski Hospital
Start Date
2021-03-01
Trial ID
NCT04452461
Treatments Being Tested
This phase II trial compares the effect of adding radiation therapy to the ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-10-18
Trial ID
NCT06350162
Treatments Being Tested
The goal of this study is to use ultra-high-resolution (UHR) PET imaging to...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-02-13
Trial ID
NCT07509125
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
The aim of this study is the safety and efficacy of cryosurgery plus NK imm...
Status
Completed
Location
Cancer Institute in Fuda cancer hospital
Start Date
2016-07-01
Trial ID
NCT02843815
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184